Akebia Therapeutics Inc. (AKBA) jumped 5.87% or 0.8 to $14.42. It is near 423155 shares traded, which is 153.68% compare to the average total volume 275341. The market cap of AKBA is $681.62 million. The year to date change is -9.02%. The 52 week price range is from $8.58 to $20.25. Price of AKBA have changed -5.87% during last week. It have changed -10.51% over last month, -12.07% over last 3 months, -8.96% over last 6 months and 34.32% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKBA is 15.02. It is 4.16% above current price. The 200-day Moving Averages for AKBA is 15.39. It is 6.73% above current price. The 52-week High is 20.25. It is 40.43% from the current price. The 52-week Low is 8.58. It is -40.50% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of AKBA is 10.68 on 2018-01-31. Short % to float is 7.21%. There are some statistics of AKBA. It is has market cap $681.62 million. The share outstanding is 47.27 million. The average volume is 275341. The revenue is 92.20M. The percent of top 15 Institution holding is 68.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKBA is -123.92%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKBA is -49.32%.